WallStSmart

Healthpeak Properties Inc (DOC)vsSabra Healthcare REIT Inc (SBRA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Healthpeak Properties Inc generates 252% more annual revenue ($2.87B vs $815.66M). SBRA leads profitability with a 19.2% profit margin vs 7.7%. DOC appears more attractively valued with a PEG of 4.08. SBRA earns a higher WallStSmart Score of 59/100 (C).

DOC

Buy

54

out of 100

Grade: C-

Growth: 8.0Profit: 4.5Value: 4.7Quality: 4.5
Piotroski: 2/9Altman Z: 0.24

SBRA

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 7.0Value: 6.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DOCUndervalued (+37.5%)

Margin of Safety

+37.5%

Fair Value

$27.14

Current Price

$19.79

$7.35 discount

UndervaluedFair: $27.14Overvalued
SBRAUndervalued (+84.2%)

Margin of Safety

+84.2%

Fair Value

$124.38

Current Price

$18.46

$105.92 discount

UndervaluedFair: $124.38Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DOC2 strengths · Avg: 9.0/10
EPS GrowthGrowth
363.9%10/10

Earnings expanding 363.9% YoY

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

SBRA3 strengths · Avg: 8.7/10
Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Areas to Watch

DOC4 concerns · Avg: 3.0/10
Return on EquityProfitability
2.8%3/10

ROE of 2.8% — below average capital efficiency

Profit MarginProfitability
7.7%3/10

7.7% margin — thin

Debt/EquityHealth
1.373/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SBRA4 concerns · Avg: 3.0/10
P/E RatioValuation
29.7x4/10

Moderate valuation

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.282/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : DOC

The strongest argument for DOC centers on EPS Growth, Price/Book.

Bull Case : SBRA

The strongest argument for SBRA centers on Operating Margin, Price/Book, Revenue Growth. Profitability is solid with margins at 19.2% and operating margin at 31.4%. Revenue growth of 21.7% demonstrates continued momentum.

Bear Case : DOC

The primary concerns for DOC are Return on Equity, Profit Margin, Debt/Equity. A P/E of 64.7x leaves little room for execution misses.

Bear Case : SBRA

The primary concerns for SBRA are P/E Ratio, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

DOC profiles as a value stock while SBRA is a growth play — different risk/reward profiles.

DOC carries more volatility with a beta of 1.03 — expect wider price swings.

SBRA is growing revenue faster at 21.7% — sustainability is the question.

DOC generates stronger free cash flow (237M), providing more financial flexibility.

Bottom Line

SBRA scores higher overall (59/100 vs 54/100), backed by strong 19.2% margins and 21.7% revenue growth. DOC offers better value entry with a 37.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthpeak Properties Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are rented to physicians, hospitals and healthcare delivery systems.

Visit Website →

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Want to dig deeper into these stocks?